GW Pharmaceuticals plc logo
GW Pharmaceuticals plc GWPH
$ 218.96 0.0%

GW Pharmaceuticals plc Long-Term Debt 2011-2025 | GWPH

Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.

Main characteristics:
  • Term exceeds 12 months
  • Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
  • Repaid through regular payments (interest and/or principal) over several years
Why long-term debt is needed:
  • Investment in development
    Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital.
  • Smoothing of cash flows
    A long-term payment schedule facilitates budget planning and reduces short-term financial risks.
  • Optimization of capital structure
    A combination of equity and borrowed capital can reduce the average cost of business financing.

A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.

If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.

It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.

Examples of long-term debt:
  • Mortgage loans for property purchases
  • Corporate bonds issued by a company to raise capital
  • Project financing — long-term loans for building or expanding production facilities
  • Leasing obligations for equipment or transport

Annual Long-Term Debt GW Pharmaceuticals plc

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 14.7 M - - - - - - - -
2020202020192019201820182017201720162016201520152014201420132013201220122011201116 M16 M12 M12 M8 M8 M4 M4 M00
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
14.7 M 14.7 M 14.7 M

Long-Term Debt of other stocks in the Drug manufacturers industry

Issuer Long-Term Debt Price % 24h Market Cap Country
Amryt Pharma plc Amryt Pharma plc
AMYT
188 M $ 14.7 - $ 621 M britainBritain
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
21.8 M $ 15.25 - $ 754 M usaUSA
PetIQ PetIQ
PETQ
438 M $ 13.6 1.64 % $ 400 M usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
1.52 M $ 0.6 10.11 % $ 58.2 M usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
137 M $ 0.173 -13.85 % $ 16.1 M usaUSA
Recro Pharma Recro Pharma
REPH
339 K $ 1.4 -4.76 % $ 65.3 M usaUSA
Athenex Athenex
ATNX
93 K $ 0.2 -23.39 % $ 1.76 M usaUSA
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
199 M $ 1.58 3.95 % $ 251 M usaUSA
PLx Pharma PLx Pharma
PLXP
622 K $ 0.09 -27.8 % $ 2.56 M usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
402 K $ 11.09 -3.90 % $ 97.2 M chinaChina
Lannett Company Lannett Company
LCI
615 M $ 0.66 1.15 % $ 7.11 M usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
24.1 M $ 40.0 -0.1 % $ 2.03 B schwedenSchweden
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
126 M $ 8.22 - $ 376 M usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
718 K $ 4.13 -0.24 % $ 544 M usaUSA
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
207 M $ 9.12 - $ 459 M usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
18.5 M $ 9.25 0.11 % $ 419 M usaUSA
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
29.1 M $ 1.15 -2.54 % $ 57.2 M usaUSA
Endo International plc Endo International plc
ENDP
8.15 B $ 0.29 - $ 28.9 M irlandaIrlanda
Tricida Tricida
TCDA
11.3 M $ 0.11 - $ 3.25 M usaUSA
PPD, Inc. PPD, Inc.
PPD
4.23 B $ 47.25 0.13 % $ 16.6 B usaUSA
Bausch Health Companies Bausch Health Companies
BHC
21.9 B $ 6.34 -0.78 % $ 2.31 B canadaCanada
HEXO Corp. HEXO Corp.
HEXO
29 M $ 0.71 2.45 % $ 38.1 M -
Veru Veru
VERU
2.92 M $ 4.41 1.38 % $ 595 M usaUSA
Neptune Wellness Solutions Neptune Wellness Solutions
NEPT
17.1 M $ 0.2 -45.3 % $ 917 K canadaCanada
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.
TARO
4.98 M $ 42.97 - $ 1.62 B israelIsrael
Viatris Viatris
VTRS
18 B $ 9.97 -1.68 % $ 12.1 B usaUSA
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
2.55 B $ 116.3 - $ 26.6 B irlandaIrlanda
cbdMD cbdMD
YCBD
2.4 M $ 1.43 -3.38 % $ 6.17 M usaUSA
FSD Pharma FSD Pharma
HUGE
147 K $ 5.84 5743.5 % $ 69.7 M canadaCanada
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
343 K $ 0.78 0.86 % $ 117 M usaUSA
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
120 K $ 1.3 - $ 55.5 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
3.81 K $ 3.25 -0.31 % $ 3.64 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
256 K $ 5.54 - $ 142 M usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
106 K $ 5.41 -6.08 % $ 184 M chinaChina
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
2.16 B $ 5.91 2.6 % $ 892 M -
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
1.12 M $ 14.21 -1.8 % $ 1.35 B franceFrance
Johnson & Johnson Johnson & Johnson
JNJ
30.7 B $ 189.69 0.42 % $ 457 B usaUSA
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
4.94 M $ 3.67 3.2 % $ 51.6 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
295 M $ 6.1 -1.13 % $ 86.3 M -
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
56.2 M $ 2.14 -39.89 % $ 27.7 M usaUSA
OrganiGram Holdings OrganiGram Holdings
OGI
104 M $ 1.94 -1.02 % $ 402 M canadaCanada
Emergent BioSolutions Emergent BioSolutions
EBS
446 M $ 9.89 -0.3 % $ 506 M usaUSA
GlaxoSmithKline plc GlaxoSmithKline plc
GSK
22.5 B $ 43.35 -0.34 % $ 173 B britainBritain
Radius Health Radius Health
RDUS
315 K $ 30.0 - $ 1.42 B usaUSA
Solid Biosciences Solid Biosciences
SLDB
1.23 M $ 6.31 14.31 % $ 258 M usaUSA
Catalent Catalent
CTLT
4.86 B $ 63.48 - $ 11.5 B usaUSA
Pacira BioSciences Pacira BioSciences
PCRX
585 M $ 23.41 -0.89 % $ 1.08 B usaUSA
Biogen Biogen
BIIB
6.3 B $ 150.97 -0.81 % $ 22 B usaUSA